Cargando…

Therapeutic Potential of Human Amniotic Epithelial Cells on Injuries and Disorders in the Central Nervous System

Despite recent advances in neurosurgery and pharmaceuticals, contemporary treatments are ineffective in restoring lost neurological functions in patients with injuries and disorders of the central nervous system (CNS). Therefore, novel and effective therapies are urgently needed. Recent studies have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huiming, Zhang, Jiaofei, Tsang, Kam Sze, Yang, Hao, Gao, Wei-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886344/ https://www.ncbi.nlm.nih.gov/pubmed/31827529 http://dx.doi.org/10.1155/2019/5432301

Ejemplares similares

Placental Amniotic Epithelial Cells and Their Therapeutic Potential in Liver Diseases
por: Tahan, Asli Ceren, et al.
Publicado: (2014)

Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders
por: Hong, Hongxiang, et al.
Publicado: (2022)

Disorders of the effective osmolality in central nervous system injury
por: Balík, M, et al.
Publicado: (1998)

The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases
por: Zuo, Shilun, et al.
Publicado: (2016)

MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
por: Zhang, Wen-Hao, et al.
Publicado: (2023)

Deoxyribozymes: New Therapeutics to Treat Central Nervous System Disorders
por: Grimpe, Barbara
Publicado: (2011)

Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
por: Terada, Kazuki, et al.
Publicado: (2019)

The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches
por: Schiavone, Stefania, et al.
Publicado: (2021)

A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders
por: Wróbel-Biedrawa, Dagmara, et al.
Publicado: (2022)

The lymphatic system: a therapeutic target for central nervous system disorders
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
por: Yang, Mengbo, et al.
Publicado: (2022)

Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2020)

Changes in Culture Expanded Human Amniotic Epithelial Cells: Implications for Potential Therapeutic Applications
por: Pratama, Gita, et al.
Publicado: (2011)

ADAMTS expression and function in central nervous system injury and disorders
por: Gottschall, Paul E., et al.
Publicado: (2015)

Effects of amniotic epithelial cell transplantation in endothelial injury
por: Vácz, Gabriella, et al.
Publicado: (2016)

Novel Therapeutic Delivery of Nanocurcumin in Central Nervous System Related Disorders
por: Panzarini, Elisa, et al.
Publicado: (2020)

Nucleic acid-based therapeutics for the treatment of central nervous system disorders
por: McCartan, Robyn, et al.
Publicado: (2023)

Long Non-coding RNA HOTAIR in Central Nervous System Disorders: New Insights in Pathogenesis, Diagnosis, and Therapeutic Potential
por: Wang, Jialu, et al.
Publicado: (2022)

Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
por: Panchal, Sunil K., et al.
Publicado: (2022)

Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
por: Zhang, Ying, et al.
Publicado: (2021)

Mitochondrial transplantation strategies as potential therapeutics for central nervous system trauma
por: Gollihue, Jenna L., et al.
Publicado: (2018)

A potential therapeutic target: The role of neutrophils in the central nervous system
por: Salken, Isabel, et al.
Publicado: (2023)

Role of Adiponectin in Central Nervous System Disorders
por: Bloemer, Jenna, et al.
Publicado: (2018)

Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021)

Progress and Promise of Nur77-based Therapeutics for Central Nervous System Disorders
por: Liu, Lu, et al.
Publicado: (2021)

Central Facial Nervous System Biomolecules Involved in Peripheral Facial Nerve Injury Responses and Potential Therapeutic Strategies
por: Lee, Jae-Min, et al.
Publicado: (2023)

Birth Injuries of the Central Nervous System
Publicado: (1928)

Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells
por: Bustamante-Barrientos, Felipe A., et al.
Publicado: (2023)

Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system
por: Simon, Florian, et al.
Publicado: (2019)

Reactive Astrocytes in Central Nervous System Injury: Subgroup and Potential Therapy
por: Yu, GuiLian, et al.
Publicado: (2021)

Drugs in Central Nervous System Disorders
por: Perry, Bruce D.
Publicado: (1985)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

Mitochondria and Central Nervous System Disorders
por: Knedlik, Tomas, et al.
Publicado: (2022)

Zinc and Central Nervous System Disorders
por: Wang, Bangqi, et al.
Publicado: (2023)

NLRC5: A Potential Target for Central Nervous System Disorders
por: Zhang, Lu, et al.
Publicado: (2021)

Vitamin C improves the therapeutic potential of human amniotic epithelial cells in premature ovarian insufficiency disease
por: Hou, Shunyu, et al.
Publicado: (2020)

Microarray analysis of verbenalin-treated human amniotic epithelial cells reveals therapeutic potential for Alzheimer’s Disease
por: Ferdousi, Farhana, et al.
Publicado: (2020)

Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
por: Huang, Yinrou, et al.
Publicado: (2023)

The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
por: Tan, Rui, et al.
Publicado: (2023)

Brain delivering RNA-based therapeutic strategies by targeting mTOR pathway for axon regeneration after central nervous system injury
por: Li, Ming-Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_48nqu7rcameg271qrdng8ltgg8